baber/WOPTO huggingface dataset:
Patent PL-1733114-T3 (PL)
Title: Drum housing
Inventor: BRAUER HANS-GEORG
IPC: E05F15/16
Filed: 2005-03-24
Abstract: The invention relates to a drum housing, a hybrid door for a motor vehicle with a door module with a mounting area for mounting a cable drum of a either a power or manual window lift drive, whereby the mounting area exhibits a first area with a first diameter that is sufficient for mounting the cable drum for the power window lift, and a second area with a second diameter that is sufficient for mounting the cable drum for the manual window lift.
Patent PL-1817326-T3 (PL)
Title: INDUSTRIAL PROCESS FOR THE PREPERATION OF 17-HYDROXY -6 BETA, 7-BETA, 15-BETA, 16-BETA-BISMETHYLENE-3-OXO 17α-ALPHA PREGN-4-ENE-21-CARBOXYLIC ACID GAMMA-LACTONE AND KEY INTERMEDIATES FOR THIS PROCESS
Inventor: Sörös Béla 
IPC: C07J53/00
Filed: 2005-10-11
Abstract: The invention relates to an industrial process for the preparation of 17-hydroxy-6β,7β;15β,16β-bismethylene-3-oxo-17α-pregn-4-ene-21-carboxylic acid γ-lactone of formula (I), and to the key-intermediates for this process.
Patent PL-1885314-T3 (PL)
Title: Absorbent single-use article
Inventor: SWEREV MAXIMILIAN
IPC: A61F13/42
Filed: 2006-05-30
Abstract: The invention relates to an absorbent single-use article (2), comprising an absorbing body, which stores body fluids, and a back sheet (5), which is impermeable to liquids at least in sections. To this end, this liquid-impermeable back sheet (5) has a microporous breathing film, and a wetness indicator (7) in the form of a visible structured arrangement (6), which is placed directly on the film, is provided on the side of the film facing the absorbing body, the structured arrangement (6) coming off when contacted by aqueous liquid whereby rendering it unrecognizable.
Patent PL-2004509-T3 (PL)
Title: Self-closing valve
Inventor: SUFFA UDO
IPC: B65D47/20
Filed: 2007-04-11
Abstract: The self-closing valve (01), e.g. for a toiletries squeeze bottle, has a valve membrane (02) with a dispensing opening (03) and an edge (11) around it. The membrane is switched between dispensing and closed settings by pressure difference. A limit stop (04) holds the membrane in the closed setting, while a limit ring (12) lies in a sealed fit against the opening edge in the closed position. A side guide (13) extends axially for the membrane edge to slide axially against it to change into the back suction setting where a gap (15) between the membrane edge and side guide is freed.
Patent PL-2090037-T3 (PL)
Title: Method for establishing bidirectional data transmission paths in a wireless meshed communication network
Inventor: BAHR MICHAEL
IPC: H04L12/56
Filed: 2007-11-12
Abstract: In a method for establishing a bidirectional data transmission path in a wireless meshed packet-switched communication network, a logical topology in the form of at least one routing tree can be proactively established, wherein a root network node of the routing tree sends first unidirectional data transmission paths regarding routing request messages specifying the root network node to the network nodes of the communication network in periodic time intervals. A first flag is provided in the network nodes of the routing tree that can be put into two different states. Upon receipt of a routing request message, a network node only sends a second unidirectional data transfer path regarding the routing response message specifying the network node to the root-network node if the first flag is switched into a first selectable state. Thus, a bidirectional data transfer path between the root network node and the network node is established.
Patent PL-2197566-T3 (PL)
Title: Method and system for regenerating an amine-containing wash solution obtained during gas purification
Inventor: GÜNTHER LOTHAR
IPC: C10L3/10
Filed: 2008-08-12
Abstract: A method for regenerating an amine-containing scrubbing solution which is obtained during gas purification and in which CO2 and sulfur compounds are chemically bonded, as well as a system that is suitable for carrying out the method. The contaminated scrubbing solution is heated, compressed, and expanded in several stages such that CO2 and sulfur compounds are separated. The expanded scrubbing solution is subdivided into two partial streams, and one partial stream is recirculated into the process.
Patent PL-2361507-T3 (PL)
Title: Method for the preparation of homofermented feed products
Inventor: LEGARTH JENS HØFFNER
IPC: A23K10/28
Filed: 2007-07-13
Abstract: The present invention pertains to the field of liquid feed, and relates to fermented feed products, methods for their preparation, as well as uses thereof. Furthermore, the invention further relates to animal liquid feed and methods of preparing liquid feed using lactic acid bacteria. In particular, a method of preparing a fermented mixed feed is provided, comprising the steps of: (a) providing a liquid fermented product; (b) providing a feed product to be fermented; (c) combining the products from step (a) and Po. (b), and fermenting the feed product of step (b) using the liquid fermented product of step (a) as inoculum.
Patent PL-3006456-T3 (PL)
Title: Mutated pseudomonas exotoxins with reduced antigenicity
Inventor: PASTAN IRA H
IPC: A61K47/68
Filed: 2006-07-25
Abstract: The invention provides mutated Pseudomonas exotoxins (PE) that have reduced immunogenicity compared to PEs containing the native sequence. The PEs of the invention have one or more individual mutations of positions of the native sequence of PE that reduce antibody binding to one or more PE epitopes. Nucleic acids encoding the mutated PEs, chimeric molecules comprising them, compositions comprising the chimeric molecules and methods of using them, are also provided.
Patent GR-3001984-T3 (GR)
Title: 1,4-dihydropyridines, process for their preparation and their use as medicaments
Inventor: FERNANDEZ TORIJA CARLOS
IPC: C07D405/14
Filed: 1991-05-22
Abstract: 1,4-Dihydro pyridine derivs. of formula (I), and their pharmaceutically acceptable acid addition salts, are new, where R1 = straight or branched, 1-4C alkyl, opt. substd. R2 = a radical with 1 or 2 C atoms, R3 = H or an aromatic ring, opt. substd. 12 Cpds. are specifically claimed, including those where R1 = methyl, R2 = methyl, and R3 = H, 2-picolyl, or 4-fluorobenzyl; and those where R1 = ethyl, R2 = methyl, and R3 = 2-thiophenyl methyl.
Patent GR-3003496-T3 (GR)
Title: Device for infusion under pressure
Inventor: HEITMEIER ROLF
IPC: A61M5/14
Filed: 1992-01-03
Abstract: Pressure infusion apparatuses are known in which the speed of rotation of a volumetric pump is regulated by determining, from the change in weight of the fluid container per unit of time, the conveyed volume current and comparing the latter with an intended value of infusion rate. Such systems are susceptible to the breakdown or the failure of individual components. In order to increase the reliability against failure, according to the invention a monitoring channel (15, 27, 28, 30) is provided in addition to the gravimetric measurement channel (10, 18, 20, 22), which monitoring channel produces a second measurement value (MW2) of the volume current by measurement of the drop count. The second measurement value (MW2) may deviate only by a predetermined amount from the intended value (SW) and it may also differ only by a predetermined amount from the first measurement value (MW1); otherwise, an alarm is triggered. <IMAGE>
Patent GR-3007478-T3 (GR)
IPC: C11D3/39
Filed: 1993-03-26
Abstract: A heavy duty detergent composition having incorporated therein an acetylated sugar ether which provides bleach activation, detergency boosting and fabric softening properties to the detergent composition. The acetylated sugar ether contains at least two long chain alkyl groups. The acetylated sugar ether acts as a bleach activator by reacting with a bleaching agent, such as sodium perborate monohydrate, to generate peracetic acid. Following perhydrolysis, the compound acts as a detergency booster. The presence of a least two long chain alkyl groups induces absorption onto the fibers and a softening effect is obtained.
Patent GR-3007446-T3 (GR)
IPC: C07K14/755
Filed: 1993-03-23
Abstract: A process for the production of a highly pure antihaemophilic factor (AHF or factor VIII) which is free of viruses owing to treatment with biocompatible organic solvents/detergents, by purification of a cryoprecipitate is described and is characterised in that, before viruses are removed from the cryoprecipitate, the thawed cryoprecipitate is extracted with water which contains 1 to 3 U/ml heparin and is at pH 6.5 to 7.5, and is mixed with an aluminium hydroxide suspension and, after cooling to 10 to 18 DEG C and adjustment of the pH to 6 to 7, centrifuged or filtered and then further processed in a manner known per se. It is advantageous after the removal of the viruses for the sample to be subjected to a gel permeation chromatography on ion exchanger materials.
Patent GR-3020415-T3 (GR)
Title: Floating mounting device of an axle, especially for a sensor
Inventor: URBAN BENOIT
IPC: F16C27/08
Filed: 1996-06-20
Abstract: The present invention relates to a floating spindle mounting, in particular for a sensor. 
<??>This mounting essentially consists of a rigid housing (4) in which the spindle (1) is accommodated, and of an elastically deformable element (5) for the mounting of the rigid housing (4) in the cover (2) of the encoder proper.
Patent GR-3022197-T3 (GR)
Title: Injection moulding of thermoplastic polymers
Inventor: DE ATH RODERICK MICHAEL
IPC: B29C37/00
Filed: 1996-12-31
Abstract: PCT No. PCT/GB92/01206 Sec. 371 Date Jan. 3, 1994 Sec. 102(e) Date Jan. 18, 1994 PCT Filed Jul. 3, 1992 PCT Pub. No. WO93/01039 PCT Pub. Date Jan. 21, 1993A method and apparatus for injection moulding thermoplastic polymers wherein a layer of pressurised gas is provided between at least selected moulded parts (11) and the cooling polymer (28). The gas takes up shrinkage as the polymer cools and allows visual sink marks to be substantially eliminated. Furthermore, cycle times are reduced, fast cooling being permitted by urging the polymer (28) against the outer mould (27) and cooling the outer mould (27).
Patent GR-3021672-T3 (GR)
Title: Presence-detecting system comprising electronic transmitter-receiver devices, actuators intercommunicating by carrier waves and connectable through an incorporated plug
Inventor: BEGHELLI GIAN PIETRO
IPC: G08B25/06
Filed: 1996-11-14
Abstract: A system for detecting presences comprising devices equipped with electronic circuits for the transmission and reception of binary messages according to the technique of conveyor waves passing through the normal domestic electric network. Said devices, connected to the electric network by an incorporated plug are in addition equipped with actuators for the control (command) of the electric power equipment in order to intercommunicate at an equivalent rank level. This system consisting of an ensemble of several devices of the above-mentioned kind associated with devices having presence-detecting characteristics is capable of carrying out the function of an anti-intrusion alarm installation. <IMAGE>
Patent GR-3022382-T3 (GR)
Title: Agents for removing advanced glycosylation endproducts
Inventor: VLASSARA HELEN
IPC: C12N5/07
Filed: 1997-01-28
Abstract: The present invention relates to a method and associated agents for the inhibition and treatment of protein aging in animals by stimulating the bodies of the animals to increase their recognition and affinity for advanced glycosylation end products. Specifically, the method contemplates the administration of certain agents such as advanced glycosylation endproducts, such endproducts as are bound to the carrier, monokines that stimulate phagocytic cells to increase their activity toward advanced glycosylation endproducts, and mixtures of these materials either alone, or in conjunction with other co-stimulatory agents. Numerous diagnostic and therapeutic applications are defined, and pharmaceutical compositions are also contemplated.
Patent GR-3022974-T3 (GR)
Title: Electrical installation equipment in modular construction.
Inventor: PFAUNTSCH PETER DIPL-ING FH
IPC: H01R13/24
Filed: 1997-03-31
Abstract: An electrical installation equipment (1) of modular construction, for example a plug socket, switch or pushbutton (momentary-contact switch), parts for additional functions being designed as plug-in modules (3) which can be plugged on or plugged in. It is intended that electrical contact can be made with the plug-in modules (3) for additional functions by making sprung contact (sprung contacts (4), sprung pin receptacle (23)) with live parts which are present anyway.   <IMAGE>
Patent GR-3023700-T3 (GR)
Title: Spraying device comprising several emitting sources.
Inventor: KAIDONIS ARISTIDE
IPC: A62C3/02
Filed: 1997-06-05
Abstract: The device comprises a series of hoses (1) connected together via tees (3) by quick-connection means (2, 4, 5). On the tees are mounted, by screwing, rigid tubes, or poles (10, 11), which have means (15) for spraying droplets at their opposite end. Holding means are used for holding the rigid tubes in the desired position, which is generally vertical. These means may include a support (7), arms (16) or a tripod (17) placed on the ground, or a foot (19) to be implanted in the ground, or magnets (21) mounted on the tube, to be fixed on a suitable metal object already existing. <IMAGE>
Patent GR-3025502-T3 (GR)
Title: Drugs, their manufacture, and their use as painkillers and/or to treat inflammations in humans and animals.
Inventor: GEISSLINGER GERD
IPC: C07C57/58
Filed: 1997-11-26
Abstract: The present invention provides a medicament for the treatment of painful and/or inflammatory diseases and/or of fever with flurbiprofen, wherein the flurbiprofen is pure or preponderantly R(-)-flurbiprofen worked up in combination with conventional pharmaceutical carriers and adjuvants, to give a medicament.
Patent GR-3025517-T3 (GR)
Title: Oxamic acid derivatives as hypocholesteremic agents
Inventor: YOKOYAMA NAOKATA
IPC: C07C323/52
Filed: 1997-11-26
Abstract: Disclosed are compounds of formula <CHEM>  wherein     R is hydrogen, hydroxy, esterified hydroxy or etherified hydroxy;     R1 is hydrogen, halogen, trifluoromethyl or lower alkyl;     R2 is hydrogen, halogen, trifluoromethyl or lower alkyl; R3 is halogen, trifluoromethyl, lower alkyl, aryl, aryl-lower alkyl, cycloalkyl or cycloalkyl-lower alkyl; or     R3 is the radical <CHEM> wherein R8 is hydrogen, lower alkyl, aryl, cycloalkyl, aryl-lower alkyl or cycloalkyl-lower alkyl; R9 is hydroxy or acyloxy; R10 represents hydrogen or lower alkyl; or R9 and R10 together represent oxo;     R4 is hydrogen, halogen, trifluoromethyl or lower alkyl;     X is -NR7;     W is O or S;     R5 and R6 together represent oxo;     R7 represents hydrogen or lower alkyl; Z represents carboxyl, carboxyl derivatized as a pharmaceutically acceptable ester or as a pharmaceutically acceptable amide; and pharmaceutically acceptable salts thereof; which are useful as hypocholesteremic agents.
Patent GR-3026089-T3 (GR)
Title: Grating for swimming-pool overflow water drain channels.
Inventor: IBANEZ SAPINA MIGUEL
IPC: E04H4/12
Filed: 1998-02-11
Abstract: It comprises a number of modules (1) which are juxtaposed and which are connected together. It is characterized in that each module (1) is provided on both opposed side surfaces thereof with respective pairs of resilient fingers (6, 7) with the peculiarity that the pair of fingers (7) of one side edge are provided with respective spigots (11) and the pair of fingers (6) of the other side edge are provided with respective orifices (9) in which the said spigots (11) are engaged, determining the resilient side coupling of the modules (1) forming the grating. It is contemplated that each side of the modules (1) shall have a finger (6'a, 7'a) with spigot (11) and a finger (6', 7') having an orifice (9). It is also a feature to provide the grating with a termination (14) where it is terminated with a transversally cut module (1a). <IMAGE>
Patent GR-3026449-T3 (GR)
Title: Compounds for targeting.
Inventor: EPENETOS AGAMEMNON ANTONIOU
IPC: A61K47/48
Filed: 1998-03-26
Abstract: A compound comprising a target cell-specific portion and a directly or indirectly cytotoxic portion, characterised in that the target cell-specific portion recognises the target cell with high avidity. The cytotoxic portions of the compound may be a subunit of an oligomer, may contain a binding site for a small molecule, may be streptavidin, may be a dimeric ribonuclease or may be DNAse-I. The target cell-specific portion may comprise two or more binding sites for the target cell, may be an antibody or fragment thereof, or may be a ScFv. A compound suitable for cell agglutination, particularly haemagglutination. A compound comprising a mediator portion and a directly or indirectly cytotoxic portion wherein the mediator portion recognises a target cell-specific molecule and provides a means of indirect targeting. <IMAGE> <IMAGE> <IMAGE> <IMAGE>
Patent GR-3032324-T3 (GR)
Title: Rotary pump and motor assembly
Inventor: WHITEFIELD KEVIN
IPC: H02K11/04
Filed: 2000-01-07
Abstract: A rotary pump which is suitable for use as the pump for a vehicle power steering system has an integral motor. The pump includes a housing 16 through which a rotatable shaft 4 extends having at one end a pump rotor assembly 5. The pump rotor assembly 5 is in fluid communication with an oil cavity 15 which is in good thermal contact with the housing 16. The housing 16 functions as a heat sink. Mounted on the radially outer wall of the housing 16 is the stator 20 of the motor with the stator 20 also in good thermal contact with the housing 16. The rotor 26 of the motor is located radially outside of the stator 20 and has axially arranged magnets 27. The rotor 26 is connected to the rotatable shaft 4 by means of a radially extending wall 26b. The integral rotary pump and motor is very compact and straightforward to construct and is also capable of withstanding the heat generated by the motor components during the high demands of a vehicle steering system. <IMAGE>
Patent GR-3032365-T3 (GR)
Title: Amidino derivatives useful as nitric oxide synthase inhibitors
Inventor: CURRIE MARK G
IPC: C07C257/14
Filed: 2000-01-14
Abstract: There is disclosed amidino derivatives of formula (I), pharmaceutical compositions containing these derivatives, and their use in therapy, in particular their use as nitric oxide synthase inhibitors wherein: X is alkyl, alkenyl, alkynyl, -(CH2)kQ(CH2)l- where k is 2 or 3, l is 1 or 2 and Q is 0, Se SiY2 where Y is alkyl, S(O)z where z is 0, 1 or 2, NR where R is hydrogen or alkyl, or -(CH2)mA(CH2)n- where m is 0, 1 or 2, n is 0, 1 or 2, A is 3 to 6 membered aromatic hydrocarbon radical or 3 to 6 membered heterocyclic radical wherein 1 to 3 hetero atoms are oxygen, sulfur or nitrogen and wherein all said radicals may optionally be substituted by one or more substituents such as alkyl, alkoxy, hydroxy, halogen, nitro, cyano, trifluoroalkyl and amino; R1 may be a bond to X or hydrogen (when Q is Se), hydroxyalkyl, alkyl, alkenyl, alkynyl or haloalkyl and wherein all said radicals may optionally be substituted by one or more substituents such as alkyl, alkoxy, hydroxy, halogen, nitro, cyano, trifluoroalkyl and amino; R2 is alkyl, alkenyl, alkynyl, aromatic hydrocarbon radical, haloalkyl, hydroxylamine or heterocyclic radical wherein 1 to 3 hetero atoms are oxygen, sulfur or nitrogen and wherein all said radicals may optionally be substituted by one or more substituents such as alkyl, alkoxy, hydroxy, halogen, nitro, cyano, trifluoroalkyl and amino; and R3 is amino, alkylamine, amino acid, hydroxy, alkoxy, tetrazole or tetrazoloamine.
Patent GR-3034101-T3 (GR)
Title: Instrumentation and method for evaluating clot elastic modulus, force development and erythrocyte flexibility during clotting and dissolution.
Inventor: CARR MARCUS E JR
IPC: G01N33/49
Filed: 2000-08-02
Abstract: The performance of platelets can be best understood by monitoring both the force development and the elastic modulus of the blood clot during both clotting and dissolution of the blood clot. Intermittent application and removal of a compressive force on a blood sample (8) positioned between a pair of plates (12 and 14) throughout clot formation and dissolution provides a standard for using voltage output from a transducer (22) to determine force and elastic modulus parameters. Force development arises from the internal actions of the platelets during clot retraction. Elastic modulus provides a measure of the stiffness of the clot. Clotting can be measured as an increase in force development and clot elastic modulus. Clot dissolution can be determined by a dramatic decrease in force development and in elastic modulus. Providing the blood sample with a clot dissolving agent such as tPA allows determining the fibrinolytic potential of whole blood and, thus, aids in identifying patients at risk for thrombosis due to a decreased ability to dissolve clots. Clot elastic modulus provides a measure of erythrocyte flexibility.
Patent DK-0722730-T4 (DK)
Inventor: OSHLACK BENJAMIN
IPC: A61K47/44
Filed: 1992-11-25
Granted: 2013-11-18
Abstract: (A) Controlled release oxycodone formulation for oral admin. to human patients, comprises (i) 10-40mg oxycodone or its salt, the formulation providing a mean max. plasma conc. of oxycodone of 6-60 ng/ml from a mean of 2-4.5 hrs.. After admin., and a mean min. plasma conc. of 3-30 ng/ml from a mean of 10-14 hrs. after repeated admin. every 12 hrs. through steady state conditions. (ii) 10-160 mg oxycodone or its salt, the formulation providing a mean max. plasma conc. of oxycodone of 6-240 ng/ml from a mean of 2-4.5 hrs. after admin., and a mean min. plasma conc. from 3-120 ng/ml from a mean of 10-14 hrs. after repeated admin. every 12 hrs. through steady-state conditions. (B) Also claimed is a solid controlled release oral dosage form comprising (i) oxycodone or its salt in amt. of 10-160 mg; a controlled release matrix selected from hydrophilic hydrophobic polymers, digestible opt. substd. 8-50C hydrocarbons, and/or polyalkylene glycols; and a diluent; wherein the compsn. provides a mean max. plasma conc. of oxycodone of 6-240 ng/ml from a mean of 2-4.5 hrs. after admin, and mean min. plasma conc. of 3-120 ng/ml from a mean of 10-14 hrs. after repeated admin. every 12 hrs. through steady-state conditions; or (ii) an analgesically effective amt. of spheroids comprising oxycodone or its salt and either a spheronising agent or an acrylic polymer or copolymer, such that the total dosage of oxycodone in the dosage form is 10-160 mg; a film coating which controls the release of the oxycodone or its salt at a controlled rate in an aq. medium, wherein the compsn. provides an in vitro dissolution rate of the dosage form.
Patent TR-200401862-T4 (TR)
Inventor: CORSI MAURO
IPC: A61K31/137
Filed: 2001-03-09
Abstract: An antagonist of the metabotropic glutamate receptor 5 (mGluR5) is useful in tolerance or dependence therapy. Such an antagonist can therefore be used in the treatment of substance tolerance or dependence, bulimia nervosa, anorexia nervosa, gambling dependence, sex dependence or obsessive compulsive disorders.
Patent TR-201809113-T4 (TR)
Title: Elektrostatik filtre, elektrostatik filtre için yük kontrol programı, ve elektrostatik filtre için yük kontrol yöntemi.
Inventor: SHIGEKI UMASE
IPC: B03C3/68
Filed: 2014-01-29
Abstract: Bir yükleme süresi periyodunda (T1) bir kuru elektrostatik filtre (10), bir yüksek voltajlı güç kaynağından bir toplama hedef objesini yüklemeye yönelik bir akım olan DCON çıkarmaktadır. Ardından, bir birinci süre periyodu (T2-1) bir yüklemeyi durdurma süresi periyodunun (T2) başladığı bir süreden geçtikten sonra bir ikinci süre periyodunda (T2-2), söz edilen kuru elektrostatik filtre, DCON'dan küçük ve bahsedilen birinci süre periyodundaki (T2-1) bir akımdan büyük bir akım olan DCBC'yi yüksek voltajlı güç kaynağından çıkarmaktadır.